JP2021518400A5 - - Google Patents
Info
- Publication number
- JP2021518400A5 JP2021518400A5 JP2020550712A JP2020550712A JP2021518400A5 JP 2021518400 A5 JP2021518400 A5 JP 2021518400A5 JP 2020550712 A JP2020550712 A JP 2020550712A JP 2020550712 A JP2020550712 A JP 2020550712A JP 2021518400 A5 JP2021518400 A5 JP 2021518400A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- hydrogen
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862647227P | 2018-03-23 | 2018-03-23 | |
| US62/647,227 | 2018-03-23 | ||
| US201962821831P | 2019-03-21 | 2019-03-21 | |
| US62/821,831 | 2019-03-21 | ||
| PCT/IB2019/052364 WO2019180683A1 (en) | 2018-03-23 | 2019-03-22 | Sting modulator compounds with sulfamate linkages, and methods of making and using |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518400A JP2021518400A (ja) | 2021-08-02 |
| JP2021518400A5 true JP2021518400A5 (cg-RX-API-DMAC7.html) | 2022-03-29 |
| JP7337086B2 JP7337086B2 (ja) | 2023-09-01 |
Family
ID=66397323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550712A Active JP7337086B2 (ja) | 2018-03-23 | 2019-03-22 | スルファメート結合を有するstingモジュレーター化合物、及び製造及び使用の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20210015915A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3768685A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7337086B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019180683A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL280430B2 (en) | 2016-03-18 | 2023-11-01 | Univ Texas | Cyclic dinucleotide compounds and methods of use |
| PH12020550585A1 (en) | 2017-11-10 | 2021-04-19 | Takeda Pharmaceuticals Co | Sting modulator compounds, and methods of making and using |
| US11203610B2 (en) | 2017-12-20 | 2021-12-21 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | 2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein |
| JP7037667B2 (ja) | 2017-12-20 | 2022-03-16 | インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. | Stingアダプタータンパク質を活性化するホスホン酸結合を有する3’3’環状ジヌクレオチド |
| TWI818007B (zh) | 2018-04-06 | 2023-10-11 | 捷克科學院有機化學與生物化學研究所 | 2'3'-環二核苷酸 |
| TWI833744B (zh) | 2018-04-06 | 2024-03-01 | 捷克科學院有機化學與生物化學研究所 | 3'3'-環二核苷酸 |
| US20230141284A1 (en) | 2020-04-10 | 2023-05-11 | Ono Pharmaceutical Co., Ltd. | Cancer therapeutic method |
| MX2023002797A (es) * | 2020-09-08 | 2023-05-04 | Univ Texas | Composiciones activadoras de sting polivalente y usos de las mismas. |
| JP7397996B2 (ja) * | 2020-11-09 | 2023-12-13 | 武田薬品工業株式会社 | 抗体薬物コンジュゲート |
| CA3198433A1 (en) * | 2020-11-11 | 2022-05-19 | Wuming YAN | Oligonucleotides, reagents and preparation thereof |
| CN117337292A (zh) | 2021-05-12 | 2024-01-02 | 勃林格殷格翰国际有限公司 | 作为cGAS抑制剂的具有N-连接环状取代基的吡啶衍生物 |
| CA3267076A1 (en) * | 2022-11-09 | 2024-05-16 | Boehringer Ingelheim International Gmbh | CYCLIC PYRIDINE DERIVATIVES USED AS CGAS INHIBITORS |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016538344A (ja) | 2013-11-19 | 2016-12-08 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | 癌処置としてのstingアゴニストの使用 |
| EP3071229A4 (en) * | 2013-11-22 | 2017-05-10 | Brock University | Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants |
| EP3152217B1 (en) | 2014-06-04 | 2018-08-01 | GlaxoSmithKline Intellectual Property Development Limited | Cyclic di-nucleotides as modulators of sting |
| BR112016030787B1 (pt) | 2014-07-01 | 2022-12-20 | Takeda Pharmaceutical Company Limited | Entidade química, composição farmacêutica e seu uso |
| EP3233191A1 (en) | 2014-12-16 | 2017-10-25 | Invivogen | Combined use of a chemotherapeutic agent and a cyclic dinucleotide for cancer treatment |
| DK3233882T3 (da) * | 2014-12-16 | 2020-01-27 | Kayla Therapeutics | Fluorinerede cykliske dinukleotider til cytokininduktion |
| GB201501462D0 (en) | 2015-01-29 | 2015-03-18 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| TWI706958B (zh) | 2015-03-10 | 2020-10-11 | 美商艾杜諾生物科技公司 | 活化「干擾素基因刺激因子」依賴性訊息傳導之組合物及方法 |
| CN108137641B (zh) | 2015-08-13 | 2022-04-01 | 默沙东公司 | 作为sting激动剂的环状双核苷酸化合物 |
| KR20180066241A (ko) | 2015-10-28 | 2018-06-18 | 아두로 바이오테크, 인코포레이티드 | “인터페론 유전자의 자극제”-의존성 신호전달을 활성화시키기 위한 조성물 및 방법 |
| JP6411676B2 (ja) | 2015-12-03 | 2018-10-24 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Stingの調節因子としての環状プリンジヌクレオチド |
| US20180369268A1 (en) | 2015-12-16 | 2018-12-27 | Aduro Biotech, Inc. | Methods for identifying inhibitors of "stimulator of interferon gene"- dependent interferon production |
| SMT202500412T1 (it) | 2016-01-11 | 2025-11-10 | Innate Tumor Immunity Inc | Dinucleotidi ciclici per il trattamento di condizioni associate all’attività di sting quali il cancro |
| WO2017123657A1 (en) | 2016-01-11 | 2017-07-20 | Gary Glick | Cyclic dinucleotides for treating conditions associated with sting activity such as cancer |
| IL280430B2 (en) * | 2016-03-18 | 2023-11-01 | Univ Texas | Cyclic dinucleotide compounds and methods of use |
| MX2020006290A (es) * | 2017-12-15 | 2020-12-03 | Janssen Biotech Inc | Dinucleotidos ciclicos como agonistas de sting. |
-
2019
- 2019-03-22 EP EP19721764.9A patent/EP3768685A1/en not_active Withdrawn
- 2019-03-22 US US17/040,083 patent/US20210015915A1/en not_active Abandoned
- 2019-03-22 JP JP2020550712A patent/JP7337086B2/ja active Active
- 2019-03-22 WO PCT/IB2019/052364 patent/WO2019180683A1/en not_active Ceased
- 2019-03-22 EP EP23162945.2A patent/EP4242212A3/en active Pending
-
2024
- 2024-12-23 US US18/999,908 patent/US20250262298A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016509047A5 (cg-RX-API-DMAC7.html) | ||
| ES2746374T3 (es) | Compuestos terapéuticos útiles para el tratamiento profiláctico o terapéutico de una infección producida por el virus del VIH | |
| RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
| JP2021178873A (ja) | Hivカプシド阻害剤のコリン塩形態 | |
| JP2021191798A (ja) | Hivカプシド阻害剤の固体形態 | |
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP2008545660A5 (cg-RX-API-DMAC7.html) | ||
| Diana et al. | [[(4, 5-Dihydro-2-oxazolyl) phenoxy] alkyl] isoxazoles. Inhibitors of picornavirus uncoating | |
| JP2016510038A5 (cg-RX-API-DMAC7.html) | ||
| AU2019351122A1 (en) | Inhibitors of VAP-1 | |
| JP2022505525A5 (cg-RX-API-DMAC7.html) | ||
| RU2019107938A (ru) | Производное оксопиколинамида, способ его получения и его фармацевтическое применение | |
| CA2694270A1 (en) | Substituted aryloxazoles and the use thereof | |
| JOP20230035A1 (ar) | مثبطات apol1 وطرق استخدامها | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| JP2020536082A5 (cg-RX-API-DMAC7.html) | ||
| JP2019518046A5 (cg-RX-API-DMAC7.html) | ||
| JP2025505200A5 (cg-RX-API-DMAC7.html) | ||
| JP2018534355A5 (cg-RX-API-DMAC7.html) | ||
| JP2019520344A5 (cg-RX-API-DMAC7.html) | ||
| JOP20240120A1 (ar) | مشتقات 4-فينيل-2-(1h-3،2،1-تريازول-4-يل) بيبيريدين-4-أول كمثبطات لـ apol1 وطرق استخدامها | |
| JP2018502141A5 (cg-RX-API-DMAC7.html) | ||
| RU2003128985A (ru) | Производные карбамата для применения для предупреждения или лечения расстройств движений | |
| JP2022529309A5 (cg-RX-API-DMAC7.html) | ||
| RU2006130686A (ru) | Новые пиперидины в качестве модуляторов хемокинов (ccr) |